Prognostic factors in patients receiving trifluridine/tipiracil for refractory metastatic colorectal cancer in the real-life setting: The ROS study

Simple item page
dc.conference.dateJUN 30-JUL 03, 2021
dc.conference.title23rd ESMO World Congress on Gastrointestinal Cance
dc.contributor.authorGarcia-Alfonso, P.
dc.contributor.authorReina Zoilo, J.
dc.contributor.authorMata Velasco, E.
dc.contributor.authorLlanos, M.
dc.contributor.authorIllan Varella, A.
dc.contributor.authorSafont Aguilera, M.
dc.contributor.authorDelgado Urena, M.
dc.contributor.authorCastanon, C.
dc.contributor.authorPimentel, P.
dc.contributor.authorAlonso Orduna, V.
dc.contributor.authorMendez, J.
dc.contributor.authorRivera Herrero, F.
dc.contributor.authorSiso, I.
dc.contributor.authorRodriguez-Pascual, J.
dc.contributor.authorGravalos Castro, C.
dc.contributor.authorAfonso, R.
dc.contributor.authorFernandez Ranada, I.
dc.contributor.authorGrandez, R.
dc.contributor.authorMoreno, M.
dc.contributor.authorMunoz, A. Lopez
dc.contributor.authorGarcia-Paredes, B.
dc.contributor.authorAranda, E.
dc.contributor.authoraffiliation[Garcia-Alfonso, P.] Hosp Univ Gregorio Maranon, Madrid, Spain
dc.contributor.authoraffiliation[Reina Zoilo, J.] Complejo Hosp Virgen Macarena, Seville, Spain
dc.contributor.authoraffiliation[Mata Velasco, E.] Complejo Hosp Navarra, Pamplona, Spain
dc.contributor.authoraffiliation[Llanos, M.] Hosp Univ Canarias, San Cristobal la Laguna, Spain
dc.contributor.authoraffiliation[Illan Varella, A.] Hosp Virgen Puerto, Plasencia, Spain
dc.contributor.authoraffiliation[Safont Aguilera, M.] Univ Valencia, Gen Univ Hosp, Dept Med Oncol, Ciberonc, Valencia, Spain
dc.contributor.authoraffiliation[Delgado Urena, M.] Hosp Santa Ana Motril, Motril, Spain
dc.contributor.authoraffiliation[Castanon, C.] Hosp Gen, Leon, Spain
dc.contributor.authoraffiliation[Pimentel, P.] Hosp Gen Univ Santa Lucia, Santa Lucia, Spain
dc.contributor.authoraffiliation[Alonso Orduna, V.] Hosp Miguel Servet, Zaragoza, Spain
dc.contributor.authoraffiliation[Mendez, J.] Ctr Oncol Galicia, La Coruna, Spain
dc.contributor.authoraffiliation[Rivera Herrero, F.] Hospital Marques de Valdecilla, IDIVAL, Santander, Spain
dc.contributor.authoraffiliation[Siso, I.] Hosp Severo Ochoa, Madrid, Spain
dc.contributor.authoraffiliation[Rodriguez-Pascual, J.] Ctr Integral Oncol Clara Campal HM CIOCC, Madrid, Spain
dc.contributor.authoraffiliation[Gravalos Castro, C.] Hosp 12 Octubre, Madrid, Spain
dc.contributor.authoraffiliation[Afonso, R.] Hosp Ntra Sra Candelaria, Santa Cruz De Tenerife, Spain
dc.contributor.authoraffiliation[Fernandez Ranada, I.] Hosp Univ, Guadalajara, Spain
dc.contributor.authoraffiliation[Grandez, R.] Hosp Reina Sofia, Tudela, Spain
dc.contributor.authoraffiliation[Moreno, M.] Hosp Univ Puerto Real, Puerto Real, Spain
dc.contributor.authoraffiliation[Munoz, A. Lopez] Hosp Univ Burgos, Burgos, Spain
dc.contributor.authoraffiliation[Garcia-Paredes, B.] Univ Complutense, CIBERONC, Hosp Clin San Carlos, Inst Invest Hosp Clinico San Carlos IdISSC, Madrid, Spain
dc.contributor.authoraffiliation[Aranda, E.] Univ Cordoba, IMIBIC, Inst Salud Carlos III, CIBERONC,Hosp Univ Reina Sofia, Cordoba, Spain
dc.contributor.funderSpanish Cooperative Group for the Treatment of Digestive Tumours (TTD) through Laboratorios Servier S.L.
dc.date.accessioned2025-01-07T13:03:14Z
dc.date.available2025-01-07T13:03:14Z
dc.date.issued2021-07-03
dc.identifier.doi10.1016/j.annonc.2021.05.105
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttp://www.annalsofoncology.org/article/S0923753421012941/pdf
dc.identifier.urihttps://hdl.handle.net/10668/25173
dc.identifier.wosID670004200051
dc.issue.number3
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario de Puerto Real
dc.organizationSAS - Hospital Universitario Reina Sofía
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)
dc.organizationSAS - Hospital Santa Ana
dc.organizationSAS - Hospital Universitario Virgen Macarena
dc.page.numberS113-S113
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titlePrognostic factors in patients receiving trifluridine/tipiracil for refractory metastatic colorectal cancer in the real-life setting: The ROS study
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number32
dc.wostypeMeeting Abstract

Files

Collections

SAS - Hospital Universitario de Puerto Real
Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)
SAS - Hospital Santa Ana
SAS - Hospital Universitario Reina Sofía
SAS - Hospital Universitario Virgen Macarena

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía